ArticleTranslational andrology and urology2026
Anterograde release of the neurovascular bundle during nerve-sparing robot-assisted radical cystectomy: initial experience and functional outcomes in males from a case-series.
Article in Translational andrology and urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Sexual function in males after robot-assisted radical cystectomy (RARC) is often impaired. We propose a technical modification for anterograde release of the neurovascular bundle during RARC to improve functional outcomes. Case Description: In this study, we constructed a standard operative procedure to preserve the neurovascular bundle (NVB) during the RARC, and 5 consecutive patients underwent modified RARC performed by a single surgeon. Using the developed posterior prostatic capsule as a guide, anterograde release of the NVB began at the base of the prostate to the apex without suturing the dorsal vascular complex. Potency was defined as a Sexual Health Inventory for Men (SHIM) score ≥17. The median age of the patients was 64 years. No positive surgical margin was reported. One patient was postoperatively diagnosed as pT2N1 and received adjuvant chemotherapy. After a median follow-up time of 11 (range, 10-15) months, no radiographic recurrence was reported. Only the patient diagnosed as pT2N1 was considered impotent (an SHIM <17). One patient started Tadalafil usage at 4 weeks after surgery and achieved potency 1 week later. The other 3 patients recovered their potency spontaneously in 4-8 weeks. Limitations of this study are that it was a noncomparative study and with relatively low sample size. Conclusions: Anterograde release of NVB during RARC is a method with high versatility and achieves promising functional outcomes for selected bladder cancer patients in our preliminary experience. Further controlled studies are needed to confirm these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.